Sphera Biotech US Fund Submits SEC Filing
On April 27, 2026, Sphera Biotech US Fund, L.P., with CIK number 0001749475, filed a document with the SEC, as indicated in the accession number 0001749475-26-000001. The filing includes Item 3C, which pertains to the Investment Company Act Section 3(c). According to SEC EDGAR, this specifically references Item 3C.7 for Section 3(c)(7).
Details of the Filing
The document filed by Sphera Biotech US Fund, L.P. is a D/A filing with a size of 9 KB, as recorded in the SEC EDGAR system. It directly cites Section 3(c)(7) under Item 3C, which is part of the Investment Company Act. As widely known, Section 3(c)(7) relates to exemptions for certain investment companies, though specific applications in this filing are limited to the stated items.
Context of the Exemption
Section 3(c)(7) of the Investment Company Act, as referenced in the filing, applies to funds whose securities are held by qualified purchasers, a standard provision in U.S. securities regulations. According to SEC EDGAR, the filing does not provide additional details beyond Item 3C and 3C.7.
Source and Verification
This filing was submitted on April 27, 2026, and is accessible through the SEC’s EDGAR database under the provided accession number. According to SEC EDGAR, the document confirms the filer’s identity and the specific items involved.
